Pharma industry in the US and their engagement in tropical diseases

For a long time Big Pharma in the United States have neglected tropical diseases, but this is about to change with the first American infected in the US. GlaxoSmithKline has started making 10000 does of experimental Ebola vaccine others like Johnson and Johnson’s Crucell division and NewLink Genetics are close to entering the market. Pharmaceutical firms have only spent $527 million on research and development of tropical diseases a small fraction of the total spent of 130 billion. Most US pharmaceutical firms considered tropical diseases charity work. Since in a capitalist system in which industry takes all the risk in R&D and only gets returns on investment from successful products, it does not work for diseases which primarily affect low-income countries. Through the greater exposure of tropical diseases in the US, especially the Gulf coast many pharmaceutical companies have taken up the fight against tropical diseases trough WHO donations, flexible pricing and patent policies, collaborative R&D and investments in healthcare structures. This can be seen as a strategic investment in the future, since 40% of the world’s population lives in the tropics. Economic growth in those places will see many of these nations become important commercial hubs for the pharma industry.

Outside Texas Health Presbyterian Hospital in Dallas

Sources:

http://www.theguardian.com/business/2014/oct/05/ebola-america-range-big-pharma

Russia’s Growth Prospects

Vladimir Putin Russia’s president has chosen the way of conflict with the West, when he acquired the Crimea area and supported rebel groups in the Eastern Ukrainian Donbass region. The Russian economy since 2011 has been hard-pressed for adequate growth figures. In 2011 Russia had growth rates of 4.3 % of GDP in the successive years that growth has slowed down to 1.3 % in 2013. The downing of the Malaysian airlines jet finally gave the EU and US no other options then to sanction Putin’s Russia. Most threatening for the Russian economy is the sanctions against state controlled banks. These sanctions make it harder for lenders to raise equity and debt in Western capital markets. In addition to that international capital into Russia has fallen from 25 billion to 7.9 billion if compared with last year’s first half. The question which arises is if Putin really wants to go further against the interests of his country and escalate the Ukrainian conflict even further. In alienating the West Putin is reliant on countries like China for financing and more investment, which would only come in exchange for preferential access to Russia’s vast pool of natural resources. Clearly then, Russia is going to have a difficult time the next few years with low economic growth.

20140802_EUD001_0

Source:

http://www.economist.com/news/europe/21610322-cost-vladimir-putins-gamble-ukraine-going-up-he-shows-no-sign-changing?zid=295&ah=0bca374e65f2354d553956ea65f756e0

Turmoil in the smartphone market

Global smartphone sales are to grow by 18% in 2015, interestingly tough this growth is going to come from now new emerging markets, with 7 new entries in the top 10 smartphone markets expected for 2015. The reason for this strong growth is the lower pricing of some smartphones at 30$-50$, which makes a smartphone affordable to a new major population segment which earns 2000$-4000$. India is going to become the biggest smartphone market in the world. What does that mean for global smartphone producers? Samsung, Huawei and Xiaomi who offer smartphones in this price range are going to benefit from the smartphone market growth rates in emerging markets. Apple on the other hand does not offer any smartphones near to the 30-50$ range, and therefore will have a harder time benefiting from the growth in those emerging markets. Apple out of fear that a lower priced iPhone would cannibalize the demand for its premium version and lower Apple’s ridiculous high margins, sticks with a strategy of just selling high priced devices. Consequently we should expect smartphone manufacturers with greater price differentiation to benefit from the growth in emerging markets more than their rivals who rely on high pricing strategies.

k

 

Sources:

http://www.telegraph.co.uk/finance/newsbysector/mediatechnologyandtelecoms/11126997/Emerging-markets-will-lead-smartphone-growth-next-year.html

http://www.rediff.com/business/slide-show/slide-show-1-tech-apple-gets-aggressive-with-iphone-in-india/20130225.htm#4

Spam prevention powered by Akismet